2018NICE／PHE指南：支气管扩张（非囊性纤维化）急性加重抗菌药物处方（NG.117）.pdfVIP

Bronchiectasis (non-cystic fibrosis), acuteBronchiectasis (non-cystic fibrosis), acute eexacerbation: antimicrobial prescribingxacerbation: antimicrobial prescribing NICE guideline Published: 18 December 2018 .uk/guidance/ng117 © NICE 2018. All rights reserved. Subject to Notice of rights (.uk/terms-and-conditions#notice-of- rights). Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing (NG117) YYour responsibilityour responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian. ocal commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. © NICE 2018. All rights reserved. Subject to Notice of rights (.uk/terms-and- Page 2 of c